![Gilmore O’Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilmore O’Neill
Verkställande Direktör på
EDITAS MEDICINE, INC.
Förmögenhet: 859 163 $ per 2026-05-31
Profil
Gilmore O’Neill is President, Chief Executive Officer & Director at Editas Medicine, Inc. since 2022.
Dr. O’Neill is Director at Massachusetts Biotechnology Council.
Dr. O’Neill is Member at American Academy of Neurology.
Former roles include Director at Aptinyx, Inc., Independent Director at Unity Biotechnology, Inc. from 2020 to 2025, Independent Director at Aptinyx, Inc. from 2021 to 2023, Senior VP-Late Stage Clinical Development at Biogen, Inc. from 2016 to 2018, and Chief Medical Officer & Executive Vice President at Sarepta Therapeutics, Inc. from 2018 to 2021.
Education includes graduate degree from Harvard University in 1998 and undergraduate degree from University College Dublin in 1988.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EDITAS MEDICINE, INC. 0,16 % | 2026-06-03 | 248 313 ( 0,16 % ) | 859 163 $ | 2026-05-31 |
Aktiva positioner av Gilmore O’Neill
| Företag | Position | Start |
|---|---|---|
| EDITAS MEDICINE, INC. | Verkställande Direktör | 2022-06-01 |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Företagsledare/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Gilmore O’Neill
| Företag | Position | Slut |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Direktör/Styrelseledamot | 2025-06-27 |
| APTINYX | Direktör/Styrelseledamot | 2023-04-14 |
| SAREPTA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-17 |
| BIOGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-06-01 |
| APTINYX | Direktör/Styrelseledamot | - |
Gilmore O’Neills utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
84
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
